Physician profile
Peter Chen
NPI 1225100183
$17,942.62
in general payments reported to CMS, 2019-2025
9 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $525 · 2021: $9,488 · 2022: $1,400 · 2024: $6,401 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,150 · Travel and Lodging: $832 · Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,150.00 |
| Travel and Lodging | $831.69 |
| Food and Beverage | $548.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $9,201.24 | 2021-2024 | Veklury |
| Lilly USA, LLC | $3,412.50 | 2021 | |
| Life Technologies Corporation | $2,800.00 | 2021-2022 | |
| Rigel Pharmaceuticals, INC. | $1,800.00 | 2021 | |
| Eli Lilly and Company | $525.00 | 2020 | |
| Edwards Lifesciences Corporation | $128.60 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $75.28 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.